Copper Bend Pharmacy, Inc. v. Optum Rx, Inc.

2021 IL App (5th) 210083-U
Appellate Court of Illinois·Decided June 17, 2021·No. 5-21-0083·Unpublished·Cited by 1 cases

Opinion

NOTICE

2021 IL App (5th) 210083-U NOTICE

Decision filed 06/17/21. The This order was filed under text of this decision may be NO. 5-21-0083 Supreme Court Rule 23 and is changed or corrected prior to the filing of a Petition for not precedent except in the

Rehearing or the disposition of IN THE limited circumstances allowed the same. under Rule 23(e)(1).

APPELLATE COURT OF ILLINOIS

FIFTH DISTRICT

COPPER BEND PHARMACY, INC., d/b/a ) Appeal from the Copper Bend Pharmacy, et al., ) Circuit Court of ) St. Clair County.

Plaintiffs-Appellees, )

)

v. ) No. 20-L-396 )

OPTUMRX, INC., Successor by Merger to ) Catamaran Corporation, and OPTUMRX, INC., ) In Its Own Right, ) Honorable ) Heinz M. Rudolf,

Defendant-Appellant. ) Judge, presiding.

JUSTICE CATES delivered the judgment of the court.

Justices Welch and Wharton concurred in the judgment.

ORDER

¶1 Held: The circuit court did not abuse its discretion in denying the defendant’s motion to stay the proceedings in Illinois.

¶2 The plaintiffs, Copper Bend Pharmacy Inc., d/b/a Copper Bend Pharmacy, et al., filed a complaint in the circuit court of St. Clair County, alleging that the defendant, OptumRx, Inc., successor by merger to Catamaran Corporation, and OptumRx, Inc., in its own right, violated its prescription drug reimbursement agreements with the plaintiffs. The defendant filed a motion in the circuit court to compel arbitration of the plaintiffs’ claims,

and subsequently filed a nearly identical petition to compel arbitration in the federal district court in California. The defendant then moved the circuit court to stay the proceedings in St. Clair County, pending a ruling by the federal district court on the defendant’s petition to compel arbitration. After hearing arguments on the defendant’s motion to stay, the circuit court denied it. On appeal, the defendant claims that the circuit court’s decision to deny a stay of the Illinois action was an abuse of discretion in that the court ignored recognized principles of law, resulting in substantial prejudice to the defendant. For the reasons that follow, we affirm.

¶3 The plaintiffs are a group of 45 companies that operate independent pharmacies in 15 different states. Twelve companies operate independent pharmacies in Illinois. The defendant, OptumRx, is a California corporation in the business of managing prescription drug benefits programs for health benefit plans. The defendant also contracts with independent pharmacies, such as the plaintiffs, to dispense prescription drugs to members of those health benefits plans. In 2015, OptumRx merged with Catamaran Corporation (Catamaran), another prescription drug benefits manager. Catamaran was an Illinois corporation, and from 2012-2015, it contracted with independent pharmacies to dispense prescription drugs to health plan members.

¶4 In May 2020, the plaintiffs brought an action against the defendant in the circuit court of St. Clair County (“the Illinois action”). In an amended complaint filed July 24, 2020, the plaintiffs alleged, among other things, that the defendant underpaid on prescription drug reimbursement claims submitted by the plaintiffs in violation of the

defendant’s provider manuals and various state statutes. The plaintiffs claimed that the underpayments dated back to 2012 and involved premerger agreements with Catamaran.

¶5 On August 21, 2020, the defendant filed a motion to compel arbitration and to either dismiss the plaintiffs’ action or stay the proceedings pending the outcome of binding arbitration, pursuant to section 2-619(a)(9) of the Code of Civil Procedure (Code) (735 ILCS 5/2-619(a)(9) (West 2018)). The defendant argued that mandatory arbitration clauses in the defendant’s 2015-2020 provider manuals required the parties to arbitrate “any and all issues and/or disputes” in California pursuant to the Federal Arbitration Act (FAA) (9 U.S.C. § 1 et seq.). The defendant also filed a separate motion to dismiss the first amended complaint pursuant to sections 2-615 and 2-619 of the Code (735 ILCS 5/2-615, 2-619 (West 2018)). On August 24, 2020, the defendant filed a legal memorandum in support of its motion to compel arbitration, accompanied by a supporting affidavit and several exhibits.

¶6 On November 6, 2020, the defendant filed a petition in the United States District Court for the Central District of California (“the federal district court”), seeking to compel the plaintiffs to arbitrate their claims in California and to enjoin the plaintiffs from litigating those claims in Illinois (“the federal action”). Forty-four of the plaintiffs in the Illinois action were named as respondents in the federal action. One of the named plaintiffs in the Illinois action, H&H Pharmacy, a California corporation, was not included in the federal action in California.

¶7 On November 16, 2020, the plaintiffs filed a memorandum in opposition to the defendant’s motion to compel arbitration in the Illinois action. The plaintiffs argued, in

part, that the arbitration provisions in the defendant’s provider manuals did not apply retroactively; that the arbitration provisions were unconscionable as a matter of law; and that in the cases of 21 plaintiffs, the applicable provider manual did not contain an arbitration clause. The plaintiffs’ memorandum was supported by affidavits and several exhibits.

¶8 On November 25, 2020, the defendant moved the circuit court to stay the proceedings in the Illinois action, pending a ruling by the federal district court on the defendant’s petition to compel arbitration. The defendant argued that a stay would preserve the status quo, conserve the resources of the Illinois trial court, and protect the defendant from injuries arising from the plaintiffs’ failure to comply with the arbitration clauses in the applicable provider manuals. The defendant further argued that a stay would allow the federal district court in California to adjudicate the defendant’s petition to compel arbitration in accordance with the parties’ agreement to resolve “all disputes” in California. The defendant asserted that the federal district court “presumably had more exposure to, and familiarity with,” issues that arise under the FAA and the laws of California. As relief in the alternative, the defendant requested that the circuit court stay all matters involving the merits of the plaintiff’s claims until the court ruled on the defendant’s motion to compel arbitration.

¶9 On January 7, 2021, the plaintiffs filed a memorandum in opposition to the defendant’s motion to stay the proceedings in Illinois. The plaintiffs argued that the decision to grant or deny a stay within the discretion of the circuit court, and that none of the factors that the court was to consider favored a stay of the proceedings in Illinois. The

plaintiffs also argued that their right to choose a judicial forum for their claims would be illusory if the defendant could deprive them of their selected forum by filing a duplicative action in another court. The plaintiffs also noted that the Illinois action would proceed as to at least one of the plaintiffs, H&H Pharmacy, regardless of the ruling in the federal action.

¶ 10 On January 28, 2021, the circuit court held a hearing on the defendant’s motion to stay the proceedings in Illinois. After hearing the arguments of counsel, the circuit court took the matter under advisement and gave the parties the opportunity to submit proposed orders. On March 1, 2021, the circuit court issued a written order, denying the defendant’s motion to stay the proceedings and articulating the reasons for its decision. This appeal followed.

Free access — add to your briefcase to read the full text and ask questions with AI

Copper Bend Pharmacy, Inc. v. Optum Rx, Inc., 2021 IL App (5th) 210083-U (Ill. Ct. App. 2021).

2021 IL App (5th) 210083-U (Copper Bend Pharmacy, Inc. v. Optum Rx, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bridgeton Landfill, LLC v. Continental Casualty Company
2024 IL App (1st) 231949-U (Appellate Court of Illinois, 2024)